|
RESEARCH AND LICENSE AGREEMENT (Details Textual) (USD $)
In Thousands, except Share data, unless otherwise specified
|
1 Months Ended |
12 Months Ended |
111 Months Ended |
|
Jan. 31, 2011
|
Dec. 31, 2009
|
Dec. 24, 2009
|
| Research License Agreement Expenses Paid |
|
|
$ 400 |
| Research License Payments Made As Per Settlement Agreement |
|
5 |
|
| Shares Granted As Per Research and License Agreement |
|
1,120,000 |
|
| Number Of Days Of Restriction To Sell Shares In Open Market |
|
185 days |
|
| Number Of Shares Sold By Purchaser As Permitted By Settlement Agreement |
|
167,530 |
|
| Proceeds From Sale Of Shares Are Less Than240 Conditions |
|
"Company shall pay to Ramot the difference between the proceeds that Ramot has received from sales of the shares up to such date together with the September Payment (if any) that has been transferred to Ramot up to such date, and $240." |
|
| Proceeds From Shares Sold By Purchaser As Permitted By Settlement Agreement |
35 |
|
|
| Total Value Of Shares Sold By Purchaser |
235 |
|
|
| Obligation Amount To Fund Extended Research Period |
|
|
1,140 |
| Research and Development Expenses Reversed |
|
760 |
|
| Stock Based Compensation Related To Shares Granted Under Research License Agreement |
|
51 |
|
| Research License Interest Rate |
|
|
32 |
|
Initial Research Period [Member]
|
|
|
|
| Research License Liability |
|
|
240 |
|
Extended Research Period [Member]
|
|
|
|
| Research License Liability |
|
|
$ 380 |